MDxHealth S.A. (MDXH) Key Statistics & Financial Ratios

MDxHealth S.A. (MDXH) — Price $0.65 HealthcareMedical - Diagnostics & Research — NASDAQ

Latest reported results:

Key statistics dashboard for MDxHealth S.A. (MDXH). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.

MDxHealth SA is a commercial-stage precision diagnostics firm delivering specialized urologic solutions across the globe. Its international footprint includes the United States, various European nations such as the Netherlands, Belgium, Spain, Poland, Italy, and the wider European Union. The company's innovative genomic testing portfolio for prostate cancer comprises SelectMDx, a non-invasive urine test, and ConfirmMDx, an epigenetic diagnostic tool.

Stock Data

Price$0.65
Market Cap$33M
Enterprise Value$120.4M
Beta0.38
ExchangeNASDAQ
CountryBE

Valuation Multiples

P/E Ratio-1.14
Price / Book-1.16
P/S0.42
EV/EBITDA-15.54
EV/Sales1.47
EV/FCF-21.64
P/FCF-6.20
Earnings Yield-87.98%
FCF Yield-16.48%
Dividend Yield0.00%

Profitability

Gross Margin57.64%
EBIT Margin-18.09%
EBITDA Margin-9.46%
Operating Margin-20.36%
Net Margin-37.02%
Return on Equity142.63%
Return on Assets-22.94%
Return on Invested Capital-16.67%
Return on Capital Employed-17.60%

Financial Health

Current Ratio1.15
Quick Ratio0.98
Cash Ratio0.51
Debt / Equity-3.48
Debt / Assets80.13%
Net Debt / EBITDA-11.18
Interest Coverage-1.15
Piotroski F-Score3
Altman Z-Score-2.73

Per-Share Data

Revenue per share1.56
Book Value per share-0.58
Cash per share0.37
FCF per share-0.11
Tangible Book Value per share-2.03
Dividend per share0.00

Analyst Consensus

Strong Buy0
Buy6
Hold0
Sell0
Strong Sell0
Total analysts6
Avg rating (1-5)1.00

Related companies: ACRS · ASMB · IMRX · NEO · QTRX · SI · SNWV

Explore sector: Healthcare · Medical - Diagnostics & Research

More sections of MDXH: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events

Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks